ALPS
Alps Group Inc
NASDAQ · Healthcare · Biotechnology · MY
$0.37
−2.63%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−1.0x
Market Cap
$61.57M
MomentumView details →
1D Return
−2.63%
YTD Return
−57.43%
RSI (14)
45.7
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−1.0x
Market Cap
$61.57M
RSI (14)
45.7
MomentumView details →
1D Return
−2.63%
YTD Return
−57.43%
Similar companies
Latest newsMore news →
Alps Group Inc reported fiscal year 2026 financial results with revenue growing 44% to $4.9 million, driven by growth across cellular therapy, medical testing, laboratory, aesthetics beauty services, and healthcare products.28d agoTecnam proposes to launch a new regional airline under its Altair subsidiary to operate P2012 Traveller aircraft for regional air mobility services in Italy.53d ago